治疗肺动脉高压的新药研究

被引：3

作者：

沈节艳

沈兰

机构：

[1] 上海交通大学医学院附属仁济医院心内科

来源：

内科理论与实践 | 2008年 / 3卷 / 06期

关键词：

肺动脉高压; 新药研究; 5-羟色胺再摄取抑制剂; 可溶性鸟苷环化酶激动剂; 血小板源性生长因子受体拮抗剂;

D O I：

暂无

中图分类号：

R543.2 [肺动、静脉疾病];

学科分类号：

100201 [内科学];

摘要：

<正>肺动脉高压(PAH)是一种危及生命的疾病,其特点是肺动脉压力和肺血管阻力进行性升高,最终导致右心功能衰竭和死亡。PAH的定义是静息状态下肺动脉平均压≥25mmHg(1mmHg=0.133kPa)或运动时肺动脉平均压≥30mmHg,肺毛细血

引用

页码：407 / 411

页数：5

共 15 条

[1]

Single-Dose Pharmacokinetics; Pharmacodynamics; Tolerability; and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63–2521: An Ascending-Dose Study in Healthy Male Volunteers.[J].Reiner Frey;Wolfgang Mück;Sigrun Unger;Ulrike Artmeier-Brandt;Gerrit Weimann;Georg Wensing.The Journal of Clinical Pharmacology.2008, 8

[2]

Effects of combined therapy with a Rho-kinase inhibitor and prostacyclin on monocrotaline-induced pulmonary hypertension in rats [J].

Tawara, Shunsuke ;

Fukumoto, Yoshihiro ;

Shimokawa, Hiroaki .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (02) :195-200

[3]

Medical Therapy for Pulmonary Arterial Hypertension.[J].David B. Badesch;Steven H. Abman;Gerald Simonneau;Lewis J. Rubin;Vallerie V. McLaughlin.Chest.2007, 6

[4]

Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice [J].

Abe, Kohtaro ;

Tawara, Shunsuke ;

Oi, Keiji ;

Hizume, Takatoshi ;

Uwatoku, Toyokazu ;

Fukumoto, Yoshihiro ;

Kaibuchi, Kozo ;

Shimokawa, Hiroaki .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 48 (06) :280-285

[5]

Thrombotic arteriopathy and anticoagulation in pulmonary hypertension [J].

Johnson, Sindhu R. ;

Granton, John T. ;

Mehta, Sanjay .

CHEST, 2006, 130 (02) :545-552

[6]

Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension [J].

Kawut, Steven M. ;

Horn, Evelyn M. ;

Berekashvili, Ketevan K. ;

Lederer, David J. ;

Widlitz, Allison C. ;

Rosenzweig, Erika B. ;

Barst, Robyn J. .

PULMONARY PHARMACOLOGY & THERAPEUTICS, 2006, 19 (05) :370-374

[7]

Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling [J].

Dumitrascu, R ;

Weissmann, N ;

Ghofrani, HA ;

Dony, E ;

Beuerlein, K ;

Schmidt, H ;

Stasch, JP ;

Gnoth, MJ ;

Seeger, W ;

Grimminger, F ;

Schermuly, RT .

CIRCULATION, 2006, 113 (02) :286-295

[8]

New predictors of outcome in idiopathic pulmonary arterial hypertension.[J].Steven M. Kawut;Evelyn M. Horn;Ketevan K. Berekashvili;Robert P. Garofano;Rochelle L. Goldsmith;Allison C. Widlitz;Erika B. Rosenzweig;Diane Kerstein;Robyn J. Barst.The American Journal of Cardiology.2005, 2

[9]

Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats [J].